The estimated Net Worth of Dean J. Childers is at least 248 千$ dollars as of 29 June 2018. Dean Childers owns over 7,000 units of Invacare stock worth over 22,856$ and over the last 9 years Dean sold IVC stock worth over 225,642$.
Dean has made over 4 trades of the Invacare stock since 2016, according to the Form 4 filled with the SEC. Most recently Dean sold 7,000 units of IVC stock worth 130,970$ on 29 June 2018.
The largest trade Dean's ever made was buying 10,000 units of Invacare stock on 15 May 2016 worth over 104,000$. On average, Dean trades about 3,694 units every 86 days since 2016. As of 29 June 2018 Dean still owns at least 34,631 units of Invacare stock.
You can see the complete history of Dean Childers stock trades at the bottom of the page.
Dean's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44035.
Over the last 21 years, insiders at Invacare have traded over 3,551,958$ worth of Invacare stock and bought 391,450 units worth 2,325,949$ . The most active insiders traders include Edward F Crawford、Aaron Malachi Iii Mixon、Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of 10,700$. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth 47,900$.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: